PARTICIPATE IN RESEARCH
Move preeclampsia research forward for other women like you
Patients like you are central to moving preeclampsia research forward.
Although we now understand more about what causes preeclampsia, there are still so many unanswered questions that your experience can help us understand:
All of these questions and more are being studied by researchers around the world and right here, thanks in no small part to the Preeclampsia Foundation community and our continued drive to fund and support research on preeclampsia, HELLP syndrome, and related hypertensive disorders of pregnancy.
As a patient, the choice to participate in any research study is up to you. Here’s how YOU can get involved.
Planning a Pregnancy or Currently (12 Weeks or Less) Pregnant? Institute for Exercise and Environmental Medicine Pregnancy Research Study
This research study investigates the effect of weight gain and sleep apnea on pregnancy outcomes. We are currently recruiting women with a body mass index of 25 or greater who are pregnant (12 weeks or less) and planning to become pregnant. We are ultimately interested in understanding how the brain controls blood pressure throughout pregnancy. Participants are compensated for their time.
Please contact: Lauren Houston, R.N. at (214) 345-4607 or IEEMPregnancy@texashealth.org
The Preeclampsia Registry is a secure research database that brings your pregnancy experience(s), medical information and even your DNA, if you wish, together with leading researchers to make preeclampsia a disease of the past.
As a participant, you will join thousands of other women and families in supporting several research studies to accelerate the discoveries of the causes of preeclampsia and better options for prevention, diagnosis, and treatment.
In addition, ClinicalTrials.gov is a database of most federally and privately supported clinical trials conducted in the United States and around the world. This is a valuable resource to search for clinical trials in your area and to learn more about preeclampsia studies.
Patients are the benefactors of medical research and in the past,were often viewed as passive subjects to further new treatments and understandings of medicine. Today we have seen a shift thanks in part to advocacy organizations like ours, to recognize patients as an "n-value" and more to provide a unique, personal experience to research.
Your experiences help researchers at every stage of the research process: from study design, to recruitment, to driving participation, and even sharing results.
The Preeclampsia Foundation is regularly invited to provide your patient perspective as members of our community. For more information about patients as research partners and other ways to participate in research, please contact our Research Manager.
It is our collective voice that reduces isolation for others, raises awareness and improves healthcare practices. Let's raise up our voices so more women know about preeclampsia and HELLP syndrome and less women have adverse outcomes!
Your story is needed to improve outcomes for moms like you. Add your voice to critical preeclampsia research to ensure that every story is heard.
The Preeclampsia Foundation's published research results.
Frequently asked questions about the Preeclampsia Registry, a patient-driven registry and biobank.
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
We provide research grant funding to advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy.
May 19, 2023 – NEW YORK – Thermo Fisher Scientific announced on Friday, May 19 that it has obtained clearance from the US Food and Drug Administration for two assays to assess risk of...
A new research study published out of the UK in April 2023 in Hypertension found that more than half of all preeclampsia cases which occur during weeks 37-42 of pregnancy (“at-term”) may b...
Long-term neurodevelopmental follow-up of children exposed to pravastatin in utero If given in early pregnancy pravastatin, (a drug used to lower cholesterol) may decrease the risk of developing pree...
Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy (a rat model) Currently the only treatment for preeclampsia starts with delivery of the baby and the placenta....
The nuMom2b study – short for “Nulliparous* Pregnancy Outcomes Study: Monitoring Mothers-To-Be” – is a prospective study that enrolled over 10,000 first time pregnant women acr...